Laura Hercher, Genetic Counselor, Sarah Lawrence College
Nathan Pearson, Genomicist
0:00 Breast cancer study an incremental step . . . and a big deal?
6:55 A thorough report by the FDA supporting use of Oxitec mosquitos
11:32 Is the lack of diversity in biological studies a major weakness?
14:18 Two letter codons?
It’s the end of summer and end of another month. Joining us to discuss the genomics headlines of August are Laura Hercher and Nathan Pearson.
A recent study demonstrating that breast cancer patients with low genomic risk may not need chemotherapy is just what precision medicine is all about, isn’t it? Theral and Laura think the study is a big deal. Nathan’s not so sure.
Nathan is convinced though that Eurocentric studies have implicit racism. Laura agrees, saying the lack of racial diversity in biological databases is a major weakness that we must face head on.
Also, the FDA issued a report supporting Oxitec’s GM mosquitos for use in Florida. Laura is on board with the science but warns about smugness on the part of the scientific community. And George Church’s lab released a reengineered e. coli. Nathan imagines a new genomic language of 2 letter codons.